GLP-1s are on everyone’s minds and putting HR and benefits professionals in the hot seat. With obesity and weight loss treatments dominating healthcare conversations, plan sponsors are fielding tough questions from every direction about coverage, cost, and employee demand.   Here’s a five-step game plan to ensure plan sponsors build a thoughtful, proactive GLP-1 strategy.   1. Quantify the Demand in Your Population Before making any decisions, assess how many employees are cu

In the world of chronic disease and weight management, few breakthroughs have generated as much excitement—or delivered as much promise—as GLP1-s. Developed to treat Type 2 diabetes, drugs like Zepbound, Wegovy, and Ozempic are now making headlines for their profound impact on weight loss, cardiovascular health, and even quality of life. For many, these miracle medications are nothing short of life changing. They’re helping people sleep better, lower their blood pressure, red

As GLP-1 medications for weight loss continue exploding in popularity, plan sponsors will need to make important decisions about how to offer these treatments in a cost-effective and sustainable way. Whether it’s evaluating coverage strategies or helping members understand all their options, this guide outlines critical insights into the GLP-1 market and actionable next steps for benefits managers. Understanding GLP-1s for Weight Loss GLP-1 (Glucagon-like peptide-1) receptor